[Helicobacter pylori--friend or foe?].

Rev Med Chir Soc Med Nat Iasi

Universitatea de Medicină şi Farmacie Gr.T. Popa Iaşi, Facultatea de Medicină.

Published: March 2011

Helicobacter pylori (H. pylori) is the bacterium that causes the most common infection in the world. Epidemiological studies show that over 50% of the population is infected, there are areas where virtually the entire population present the infection since childhood. Although the stomach seems to be a "hostile" environment for the development of microorganisms due to the acid pH not fit for life, it may be infected; the first spiral organisms were described at this level as early as 1874. These microorganisms were isolated by Waren and Marshall in 1982 and named Campylobacter pyloridis. In 1989 Goodwin renamed the bacterium Helicobacter pylori. Helicobacter pylori is thus a bacterium which "manages" to survive in gastric acid environment producing an infection which, untreated, is likely to persist the entire life. This feature explains the high rate in the spread of the infection. The infection manifests itself in different ways, depending on the pathogenic strain and the host response, the majority of those infected being asymptomatic or paucysymptomatic. The great achievement of Warren and Marshall,who were rewarded with a Nobel prize in 2005, was to demonstrate that H. pylori can lead to gastric cancer, the bacteria being categorized as an oncogene agent. The anti H. pylori "campaign" was only a step away... and yet, the bacterium has been living in the stomach for centuries. We will try to list the pros and cons of H. pylori infection, when and how the infection should be treated, clearly indicating groups of patients in which eradication is absolutely mandatory. Key words:

Download full-text PDF

Source

Publication Analysis

Top Keywords

helicobacter pylori
12
pylori bacterium
8
infection infection
8
pylori
7
infection
7
[helicobacter pylori--friend
4
pylori--friend foe?]
4
foe?] helicobacter
4
pylori pylori
4
bacterium
4

Similar Publications

Therapeutic regimens against infection without proton pump inhibitors in patients with corpus atrophic gastritis: a real-life single-centre longitudinal observational study.

Therap Adv Gastroenterol

January 2025

Digestive Disease Unit, Department of Medical-Surgical Sciences and Translational Medicine, Sant'Andrea Teaching Hospital, Sapienza University of Rome, via di Grottarossa 1035, Rome 00189, Italy.

Background: Efficacy of eradication regimens in (Hp) infection is commonly reported with proton pump inhibitors (PPIs). In patients with corpus atrophic gastritis, characterized by impaired acid secretion, PPI treatment is questionable.

Objectives: The current study aimed to assess in clinical practice the tolerability and eradication rate of modified eradication regimens without PPI as first-line treatment in patients with histologically Hp-positive corpus atrophic gastritis.

View Article and Find Full Text PDF

Gold complex compounds that inhibit drug-resistant by targeting thioredoxin reductase.

Front Antibiot

August 2023

Division of Infectious Diseases, Warren Alpert Medical School of Brown University, The Miriam Hospital, Providence, RI, United States.

Introduction: There is a significant need for new antimicrobial compounds that are effective against drug-resistant microbes. Thioredoxin reductase (TrxR) is critical in redox homeostasis and was identified as a potential drug target and confirmed through inhibition by compounds auranofin and Bay11-7085.

Methods: Additional TrxR inhibitors were designed and found to exhibit antimicrobial activity against Gram-positive ( and ) and glutathione-deficient bacteria ().

View Article and Find Full Text PDF

Gastric cancer (GC) ranks among the top five most diagnosed cancers globally, with particularly high incidence and mortality rates observed in Asian regions. Despite certain advancements achieved through early screening and treatment strategies in many countries, GC continues to pose a significant public health challenge. Approximately 20% of patients infected with develop precancerous lesions, among which metaplasia is the most critical.

View Article and Find Full Text PDF

Aim: This study compared the short- and long-term efficacy of simple suture with omental patch repair (Graham patch) in open surgery versus laparoscopic omental patch repair (LOPR) in treating patients with Helicobacter pylori (H. pylori)-associated gastric ulcers with perforation, and analyzed the incidence of complications.

Methods: The clinical information of patients who had stomach perforation repair surgery in Deqing People's Hospital between January 2021 and January 2022 was retrospectively analyzed.

View Article and Find Full Text PDF

Background: The automated classification of Helicobacter pylori infection status is gaining attention, distinguishing among uninfected (no history of H. pylori infection), current infection, and post-eradication. However, this classification has relatively low performance, primarily due to the intricate nature of the task.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!